PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE
PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE
โ
de Lima Lopes, G; Chien, R; Hornberger, J
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 65 KB